Capital Change Notice – Share Option Plan

Capital Change Notice

Updated as at 17 October 2019


Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) NZRUAE0004S1
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 116,998
Nominal value (if any) Nil
Issue/acquisition/redemption price per security Nil
Nature of the payment (for example, cash or other
consideration)
Zero cash – provision of
employment and personal
services to the Issuer.
Amount paid up (if not in full) N/A (as issued for no cash
consideration).
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1

0.074% (3dp) of the total
number of Ordinary Shares on
issue (undiluted)
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Consideration for services and
performance incentive for
employees (part of
remuneration package)
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
158,136,265
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Authority was given pursuant
to a resolution dated February
2023 and in accordance with
Listing rule 4.6.1. 4.11.1 and
5.2.2(e).

1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
Share are issued pursuant to a
Share Option Deed dated
February 2023. Participant is
a good leaver and will be
required to pay associated tax
liability
Date of issue/acquisition/redemption
2
30 June 2023
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this announcement Paul Naske
Contact person for this announcement Paul Naske
Contact phone number
021445154

Contact email address
Paul.naske@ruabio.com

Date of release through MAP

30/06/2023




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).